(23), 238 (51), 207 (16), 206 (22), 179 (28), 178 (20), 147 (100), 119
(37), 100 (58), 91 (56), 59 (37) and 43 (57).
For (3aR*,4S*,7S*,7aS*,8R*)-8-acetyl-3a,4,7,7a-tetrahydro-
2,2-dimethyl-4,7-ethano-1,3-benzodioxole 28: dH (CDCl3) (data
from a mixture with 26) 6.13–6.26 (2 H, m), 4.17 (1 H, br dd,
J 3.0 and 7.2), 4.1 (1 H, overlapped), 3.8 (1 H, overlapped, 7-H),
2.94 (1 H, m, 4-H), 2.53 (1 H, ddd, J 2.7, 5.5 and 10.8, 8-H), 2.23
(3 H, s, COCH3), 1.86 (1 H, ddd, J 2.1, 5.5 and 13.5, 9-H), 1.37 (1
H, overlapped, 9-H), 1.32 (3 H, s, 2-Me) and 1.23 (3 H, s, 2-Me).
For dimethyl (3aR,4R,7S,7aS,8R,9S)-3a,4,7,7a-tetrahydro-2,2-
dimethyl-4,7-ethano-1,3-benzodioxole-8,9-dicarboxylate 25: mp
196–197 ◦C: mmax/cm−1 1742 and 1725; dH (CDCl3) 6.20 (2 H, dd, J
3.3 and 4.5, 5-H and 6-H), 4.22 (2 H, narrow m, 3a-H and 7a-H),
3.63 (6 H, s, 2 × OCH3), 3.21 (2 H, br m, 4-H and 7-H), 2.86 (2 H,
br s, 8-H and 9-H), 1.34 (3 H, s, 2-Meendo) and 1.28 (3 H, s, 2-Meexo);
saturation at d 6.20 led to NOE at d 3.21 (8%), saturation at d 4.22
led to NOEs at d 3.21 (10%), 2.86 (15%) and 1.28 (2%), saturation
at d 3.21 led to NOEs at d 6.20 (10%), 4.22 (5%) and 2.86 (4%),
saturation at d 2.86 led to NOEs at d 4.22 (15%) and 3.21 (9%),
saturation at d 1.34 led to NOE at d 6.20 (2%) and saturation at d
1.28 led to NOE at d 4.22 (7%); dC (CDCl3) 172.3 (2 × CO2), 129.4
(C-5 and C-6), 109.2 (C-2), 77.5 (C-3a and C-7a), 52.0 (2 × OCH3),
42.9 (C-8 and C-9), 39.5 (C-4 and C-7), 25.3 (2-Meendo) and 25.0
(2-Meexo); m/z 296.1249 (4%, M+, C15H20O6 requires 296.1258),
281 (27), 265 (20), 238 (16), 207 (20), 206 (29), 179 (27), 178 (17),
147 (100), 119 (33), 100 (32), 91 (56), 85 (28), 59 (42) and 43 (62).
Diels–Alder reaction of 6a with vinylene carbonate
A solution of 6a (152 mg, 1.00 mmol) and vinylene carbonate
(0.12 ml, 2.0 mmol) in benzene (8 ml), heated under reflux for
8 days, gave 29 (182 mg, 38%) and 30 (43 mg, 9%) as colourless
solids after recrystallization from hexane.
For (3aa,4b,4ab,7ab,8b,8aa)-3a,4,4a,7a,8,8a-hexahydro-6,6-
dimethyl-4,8-ethenobenzo[1,2-d:4,5-dꢀ]bis[1,3]dioxol-2-one 29:
mp 167–169 ◦C; mmax/cm−1 1796; dH (CDCl3) 6.23 (2 H, dd, J 3.0
and 4.5, 9-H and 10-H), 5.17 (2 H, br s, 3a-H and 8a-H), 4.21 (2 H,
t, J 2.1, 4a-H and 7a-H), 3.47 (2 H, m, 4-H and 8-H), 1.46 (3 H, s,
6-Mea) and 1.30 (3 H, s, 6-Meb); saturation at d 6.23 led to NOEs
at d 4.21 (1%) and 3.47 (5%), saturation at d 5.17 led to NOEs at
d 3.47 (5%) and 1.46 (0.7%), saturation at d 4.21 led to NOEs at d
6.23 (2%), 3.47 (8%) and 1.30 (1.5%), saturation at d 3.47 led to
NOEs at d 6.23 (7%), 5.17 (5%) and 4.21 (5%), saturation at d 1.46
led to NOE at d 5.17 (6%) and saturation at d 1.30 led to NOE at
d 4.21 (9%); dC (CDCl3) 155.0 (C-2), 130.5 (C-9 and C-10), 112.1
(C-6), 74.3 (C-3a and C-8a), 73.7 (C-4a and C-7a), 38.4 (C-4
and C-8), 25.8 (6-Mea) and 23.2 (6-Meb); m/z 239 (1%, M+ + 1),
223.0604 (45, M+ − CH3, C11H11O5 requires 223.0605), 180 (43),
119 (14), 107 (42), 95 (27), 94 (68), 91 (27), 79 (46), 77 (29), 66
(21) and 43 (100).
Diels–Alder reaction of 6a with 3-buten-2-one
A solution of 6a (126 mg, 0.833 mmol), a large excess (1.0 ml) of 3-
buten-2-one, and hydroquinone (10 mg) in toluene (5.0 ml), heated
at reflux for 72 h, provided 27 (119 mg, 64%) after recrystallization
from hexane, and a fraction (17 mg, 9%) containing a mixture of
26 and 28.
For (3aR*,4R*,7R*,7aS*,8R*)-8-acetyl-3a,4,7,7a-tetrahydro-
2,2-dimethyl-4,7-ethano-1,3-benzodioxole 26: dH (CDCl3) (data
from a mixture with 28) 6.22 (1 H, overlapped), 6.06 (1 H, br
t, J 7.2), 4.00–4.11 (2 H, m), 3.8 (2 H, m, overlapped), 2.84 (1 H,
m), 2.13 (3 H, s), 2.13 (1 H, m, overlapped), 1.54 (3 H, s, 2-Me),
1.53 (1 H, m, overlapped) and 1.35 (3 H, s, 2-Me).
For (3aR*,4S*,7S*,7aS*,8S*)-8-acetyl-3a,4,7,7a-tetrahydro-
2,2-dimethyl-4,7-ethano-1,3-benzodioxole 27: mp 61–62 ◦C;
mmax/cm−1 1710; dH (CDCl3) 6.17 (1 H, t, J 7.5, 5-H), 5.97 (1 H, t,
J 7.5, 6-H), 4.28 (1 H, dd, J 3.1 and 7.2, 7a-H), 4.22 (1 H, dd, J
3.2 and 7.2, 3a-H), 3.23 (1 H, m, 7-H), 2.92 (1 H, m, 4-H), 2.48 (1
H, ddd, J 2.0, 5.1 and 9.8, 8-H), 2.16 (3 H, s, COMe), 1.81 (1 H,
ddd, J 3.3, 5.1 and 13.4, 9-Hendo), 1.46 (1 H, ddd, J 2.3, 9.8 and
13.4, 9-Hexo), 1.34 (3 H, s, 2-Meendo) and 1.29 (3 H, s, 2-Meexo);
saturation at d 6.17 led to NOEs at d 5.97 (3%) and 2.92 (2%), satu-
ration at d 5.97 led to NOEs at d 6.17 (4%) and 3.23 (3%),
saturation at d 4.28 led to NOEs at d 3.23 (4%), 2.48 (8%) and
1.29 (0.6%), saturation at d 4.22 led to NOEs at d 2.92 (3%), 1.46
(4%) and 1.29 (approx. 0.5%), saturation at d 3.23 led to NOEs
at d 5.97 (5%); 4.28 (3%), 2.48 (2%) and 2.16 (1%), saturation
at d 2.92 led to NOEs at d 6.17 (5%), 4.22 (3%), 1.81 (3%) and
1.46 (1.5%), saturation at d 2.48 led to NOEs at d 4.28 (7%), 4.22
(1%), 3.23 (3%) and 1.46 (4%), saturation at d 1.81 led to NOEs
at d 2.92 (5%) and 1.46 (9%), saturation at d 1.46 led to NOEs at
d 4.22 (5%), 2.92 (2%), 2.48 (5%) and 1.81 (14%), saturation at d
1.34 led to NOEs at d 6.17 (1%) and 5.97 (1.5%) and saturation at
d 1.29 led to NOEs at d 4.28 (7%) and 4.22 (6%); dC (CDCl3) 207.5
(CO), 132.4 (C-5), 127.8 (C-6), 108.6 (C-2), 78.3 (C-3a and C-7a),
46.9 (C-8), 37.1 (C-7), 34.5 (C-4), 28.4 (COMe), 25.4 (2-Meendo),
24.9 (2-Meexo) and 22.9 (C-9); m/z 222.1247 (1%, M+, C13H18O3
requires 222.1256), 207 (13), 164 (20), 147 (7), 121 (62), 104 (19),
103 (37), 100 (26), 91 (22), 85 (20), 77 (23) and 43 (100).
For
(3aa,4b,4aa,7aa,8b,8aa)-3a,4,4a,7a,8,8a-hexahydro-6,6-
dimethyl-4,8-ethenobenzo[1,2-d:4,5-dꢀ]bis[1,3]dioxol-2-one 30:
mp 205–207 ◦C; mmax/cm−1 1772; dH (CDCl3) 6.16 (2 H, dd, J 3.3
and 4.2, 9-H and 10-H), 4.67 (2 H, br s, 3a-H and 8a-H), 4.20 (2
H, br s, 4a-H and 7a-H), 3.47 (2 H, m, 4-H and 8-H), 1.35 (3 H,
s, 6-Meb) and 1.27 (3 H, s, 6-Mea); saturation at d 6.16 led to NOE
at d 3.47 (5%), saturation at d 4.67 led to NOEs at d 4.20 (10%)
and 3.47 (7%), saturation at d 4.20 led to NOEs at d 4.67 (13%),
3.47 (7%) and 1.27 (2%), saturation at d 3.47 led to NOEs at d
6.16 (6%), 4.67 (3%) and 4.20 (3%), saturation at d 1.35 led to
NOE at d 6.16 (2%) and saturation at d 1.27 led to NOE at d 4.20
(7%); dC (CDCl3) 154.5, 128.4, 110.1, 74.5, 74.0, 38.8, 25.0 and
24.6; m/z 239 (0.5, M+ + 1), 223.0606 (53, M+ − CH3, C11H11O5
requires 223.0605), 180 (9), 119 (14), 118 (29), 107 (48), 95 (25),
94 (43), 91 (26), 79 (35), 77 (23), 59 (40) and 43 (100).
Diels–Alder reaction of 6a with tetracyanoethylene
A solution of 6a (122 mg, 0.802 mmol) and tetracyanoethylene
(102 mg, 0.802 mmol) in benzene (2.0 ml), heated under reflux for
24 h, yielded 31 (141 mg, 63%) as a pale brown solid.
For (3aa,4a,7a,7aa)-8,8,9,9-tetracyano-3a,4,7,7a-tetrahydro-
2,2-dimethyl-4,7-ethano-1,3-benzodioxole 31: mp 218–220 ◦C;
mmax/cm−1 2233 (weak); dH (CDCl3/CD2Cl2/CD3COCD3)
6.52/6.53/6.63 (2 H, dd, J 3.0 and 4.7, 5-H and 6-H),
4.76/4.79/4.87 (2 H, br s, 4-H and 7-H), 3.85/3.92/4.34 (2 H, m,
4-H and 7-H), 1.34/1.32/1.40 (3 H, s, 2-Me) and 1.34/1.32/1.33 (3
H, s, 2-Me); in CDCl3 solution, saturation at d 6.52 led to NOE at d
3844 | Org. Biomol. Chem., 2006, 4, 3838–3848
This journal is
The Royal Society of Chemistry 2006
©